Diving on ice: what I learned training with Harrogate for dream Leeds tie
Novak Djokovic’s claim he ate ‘poisoned’ food in 2022 Melbourne hotel detention ‘possible but very unlikely’, experts say
Italian mayor vows to stop sale of Neapolitan islet to wealthy speculator
Elon Musk heaps praise on AfD’s Alice Weidel during live talk on X
Brazil says Meta getting rid of factcheckers is ‘bad for democracy’
Treatment may be offered to hundreds with severe form of disease, most often found in people of Mediterranean, Asian and Middle Eastern heritage
People living with a rare genetic blood disorder in England will be offered a “life-changing” new treatment on the NHS, in what has been described as a historic moment.
Casgevy, which is a one-off gene therapy, has been approved for use on the NHS in England for people living with a severe form of thalassaemia.
More Stories
Bizarre Australian mole even more unusual than first thought, new research reveals
Male mosquitoes to be genetically engineered to poison females with semen in Australian research
Memo to Trump: US telecoms is vulnerable to hackers. Please hang up and try again | John Naughton